CD8A and neoplasm: To further evaluate the effect of FOXP3 overexpression on the therapeutic efficacy of CD8 T cells, 4-day in vitro-expanded Foxp3UP or mock OT-I cells were adoptively transferred to B16OVA tumor-bearing mice.